Correlation Between GlaxoSmithKline PLC and Schweizerische Nationalbank
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Schweizerische Nationalbank at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Schweizerische Nationalbank into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Schweizerische Nationalbank, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Schweizerische Nationalbank and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Schweizerische Nationalbank. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Schweizerische Nationalbank.
Diversification Opportunities for GlaxoSmithKline PLC and Schweizerische Nationalbank
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between GlaxoSmithKline and Schweizerische is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Schweizerische Nationalbank in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Schweizerische Nationalbank and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Schweizerische Nationalbank. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Schweizerische Nationalbank has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Schweizerische Nationalbank go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Schweizerische Nationalbank
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 0.73 times more return on investment than Schweizerische Nationalbank. However, GlaxoSmithKline PLC ADR is 1.37 times less risky than Schweizerische Nationalbank. It trades about 0.01 of its potential returns per unit of risk. Schweizerische Nationalbank is currently generating about -0.01 per unit of risk. If you would invest 3,251 in GlaxoSmithKline PLC ADR on August 25, 2024 and sell it today you would earn a total of 119.00 from holding GlaxoSmithKline PLC ADR or generate 3.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Schweizerische Nationalbank
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Schweizerische Nationalbank |
GlaxoSmithKline PLC and Schweizerische Nationalbank Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Schweizerische Nationalbank
The main advantage of trading using opposite GlaxoSmithKline PLC and Schweizerische Nationalbank positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Schweizerische Nationalbank can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Schweizerische Nationalbank will offset losses from the drop in Schweizerische Nationalbank's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Schweizerische Nationalbank vs. Israel Discount Bank | Schweizerische Nationalbank vs. Baraboo Bancorporation | Schweizerische Nationalbank vs. Danske Bank AS | Schweizerische Nationalbank vs. Jyske Bank AS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |